With 424 samples submitted to the 2026 Colorado Psychedelic Cup, testing laboratory Tryptomics is documenting an increasingly sophisticated underground ecosystem of mushroom cultivators, extract makers, and natural product entrepreneurs.

The Colorado psychedelic community has come a long way from the days when Golden Teachers and standard Psilocybe cubensis lineages dominated the psychoactive mushroom conversation. At the 2026 Colorado Psychedelic Cup that took place at Baldoria On The Water in Lakewood, Colorado on November 1st produced by the Psychedelic Club of Denver, the Colorado ‘natural elevated products’ cultivation, extraction, and product making community congregated to celebrate advances in their respective crafts under the generous protections of the state’s Proposition 122 policy. 

With 424 samples submitted across multiple categories, this year's competition offered a fascinating snapshot of the innovation happening within Colorado's psychedelic ecosystem. Tryptomics, the analytical testing laboratory serving as the event's official testing partner, provided the scientific backbone for the competition, generating detailed data on everything from mushroom alkaloid profiles to the purity of DMT extracts and the chemical composition of visionary cacti. Results from the cup are live on the Leaderboard section of the Tryptomics site, which also features data from previous iterations of the cup to help track the evolution of the mushroom space in Colorado. 

Speaking with Mycopreneur, Tryptomics team member Ian Bollinger described the event as more than a competition. In his view, the Colorado Psychedelic Cup is helping create something increasingly important to the psychedelic movement: a community gathering space where cultivators, entrepreneurs, researchers, and consumers can exchange knowledge and collectively raise standards.

Bollinger refers to this as a psychedelic "third space" — an environment outside traditional commercial and institutional structures where people can come together around shared interests and build a culture of collaboration.

Organized through a collaborative effort involving the Psychedelic Club of Denver and Tryptomics, the event demonstrated just how much the community-driven psychedelic landscape continues to evolve.

One of the most striking findings from this year's competition was the continued dominance of the TTBVI (‘Tamarind Tree British Virgin Islands’, denoting the location where this specimen was first found), a Panaeolus cyanescens lineage in the exotic mushroom category.

TTBVI has consistently occupied the upper end of the potency leaderboard since cultivators began submitting it to the competition. This year was no exception. The winning sample contained 58.53 milligrams per gram of total analyzed alkaloids, approaching 5.9% by weight.

For perspective, conventional Psilocybe cubensis varieties such as Golden Teachers frequently test considerably lower towards the 1-2 % range. The difference illustrates why simply measuring mushroom potency by weight can be misleading when comparing different genetic lineages.

TTBVI wasn't the only lineage making waves. A sample identified as Sibu reached 30.49 mg/g of total analyzed alkaloids, while Peanut Butter, Starry Night, and Hydra — a member of the unusual blob-like or ‘Enigma’ category — also posted impressive results.

The competition's organizers have increasingly separated exotic lineages from conventional cubensis varieties to ensure that cultivators working with different genetic material are evaluated within more meaningful categories.

The branching out of new categories is becoming increasingly necessary for the cup as cultivators push the boundaries of what is possible through selective breeding and genetic experimentation.

“It was great to witness the community come together in Colorado, and see analytical results of people’s work in such a collaborative space,” says Pete Belancsik of Full Canopy Genetics, a Colorado-based mushroom genetics provider that took home multiple awards for various categories including Lowest Psilocin EQ, Highest Norpsilocin for cubensis, Highest Aeruginascin for Exotics, Highest Total Analyzed for cubensis, and Highest Total Analyzed for Exotics. 

“Being in the international headquarters of natural medicine allows for great organizations like the psychedelic club of Denver, and Tryptomics, to put on amazing events like this. The psychedelic space in Colorado is a tight-knit family, and this event proved it”, continued Belancsik.

Bollinger noted that the laboratory received 71 non-cubensis samples representing 36 different Psilocybe and 35 different Panaeolus fungal species. This diversity points toward an expanding interest in species beyond the familiar Psilocybe cubensis, with cultivators becoming increasingly confident in exploring and presenting less conventional organisms.

With the number of submissions growing, Tryptomics is already considering additional category distinctions for next year's competition.

While potency numbers tend to attract the most attention, Bollinger believes the psychedelic community needs to develop a more mature understanding of mushroom chemistry.

Rather than focusing exclusively on psilocybin, Tryptomics is examining a broader collection of compounds that contribute to the overall alkaloid profile of mushrooms.

Bollinger prefers the term "ensemble effect" over the more familiar "entourage effect." He argues that the latter implies a hierarchy in which psilocybin is the star performer and other compounds play supporting roles. The ensemble analogy, by contrast, recognizes that multiple chemical components may contribute to the overall composition and potentially the subjective experience.

The laboratory has been breaking down its analysis into individual compounds, including baeocystin, norbaeocystin, aeruginascin, and norpsilocin, alongside psilocybin and psilocin.

Bollinger also wants to see greater attention paid to the hydroxy counterparts of these compounds, including 4-hydroxytryptamine (4-HT) and 4-hydroxytrimethyltryptamine (4-HTMT).

He hypothesizes that some of these compounds could influence how other substances are metabolized, including potentially competing for the attention of monoamine oxidase enzymes involved in breaking down certain compounds.

These mechanisms remain subjects for further investigation, but the larger point is that mushroom chemistry is considerably more complicated than a single percentage printed on a package.

As analytical capabilities improve, the industry is gaining access to a much more detailed picture of the chemical diversity present in different fungal lineages.

This growing body of data raises an important question: How can consumers actually use it?

A chocolate bar labeled with a particular number of mushroom grams might seem straightforward, but the actual potency can vary dramatically depending on the lineage used.

Two products containing identical amounts of mushroom biomass could deliver substantially different quantities of active compounds.

Bollinger believes producers should be more transparent about what goes into their products, including the lineage and actual mass of mushroom material used.

Tryptomics makes its leaderboard data publicly available, allowing people to look up different lineages and compare their measured alkaloid profiles. When producers disclose the lineage and amount of mushroom material in a product, consumers can use that information to better understand its chemical composition to make informed decisions around consumption.

But Bollinger argues that the responsibility shouldn't fall entirely on consumers to investigate every product themselves.

"If they are not willing to be upfront or if they're trying to obfuscate, let them know that maybe this is not the community for them," he explained.

His recommendation is straightforward: support businesses that prioritize transparency and hold those that don't to a higher standard.

In an emerging marketplace where formal regulations and standardized labeling practices remain inconsistent, community accountability could become one of the most important mechanisms for protecting consumers and encouraging responsible entrepreneurship.

Beyond mushrooms, the competition also highlighted significant advances in the DMT extraction space.

According to Bollinger, the highest-performing samples in the DMT extract category reached extraordinary levels of purity, with first, second, and third place registering 99.9%, 99.7%, and approximately 99.5% purity, respectively.

The improvement was substantial enough that samples that might have placed near the top of last year's competition would not have made the podium this time around.

Bollinger attributed these results to entrepreneurs who have been continuously refining their processes, sometimes submitting multiple iterations of their work as they improve their production systems.

The competition also recognized that not everyone is necessarily pursuing isolated compounds. Some producers are interested in preserving broader chemical profiles rather than focusing exclusively on maximizing the purity of a single molecule.

This distinction reflects a recurring theme throughout the competition: analytical testing isn't simply about determining which product contains the highest concentration of a particular compound. It's also about understanding what is actually present and giving producers the information needed to make informed decisions about product quality.

Another emerging area of interest at this year's competition was visionary cacti.

Bollinger described a growing community of people experimenting with different cactus species, extracts, and chemical profiles, particularly among members of the Echinopsis and related cactus communities.

While mescaline remains the best-known compound associated with these plants, Tryptomics is beginning to examine a wider range of constituents involved in the mescaline biosynthetic pathway.

One compound receiving attention is hordenine, which Tryptomics identified as an area deserving further investigation.

The broader opportunity is understanding how the various compounds present in visionary cacti contribute to their overall chemical profiles. Similar to the evolving conversation around minor mushroom alkaloids, this approach moves beyond treating a single molecule as the entirety of a complex botanical organism.

The cactus space remains considerably less developed commercially than the mushroom marketplace, but the growing interest in extracts and consumer-facing products suggests that it could become an increasingly important area of natural product innovation.

For entrepreneurs paying attention to emerging psychedelic markets, it represents a frontier worth watching.

Perhaps the most consequential discussion from Bollinger's interview concerned the need for better standards around psychedelic product labeling.

He proposed that producers consider reporting psilocin-equivalent quantities, or what he calls psilocin equivalents (Psilocin EQ), rather than relying exclusively on psilocybin measurements.

Psilocybin is a prodrug that is converted into psilocin in the body. Because the phosphate group contributes additional molecular mass, the psilocybin measurement does not directly represent the mass of psilocin that the compound can yield.

Bollinger suggests using a conversion factor of 0.7186 to calculate the psilocin-equivalent mass of psilocybin.

The goal is to communicate the quantity of the active compound more consistently across products and formulations.

Importantly, this is a proposed community labeling standard, not an established regulatory requirement or universally adopted scientific convention. Nevertheless, it represents an effort to move psychedelic product labeling toward greater precision and transparency.

As Colorado's regulatory environment continues to evolve, Bollinger believes the community has an opportunity to establish its own quality standards rather than waiting for policymakers to impose them.

For a movement built around personal autonomy, collective responsibility, and access to natural medicines, that distinction matters.

The Colorado Psychedelic Cup offers a compelling example of what community-driven innovation can look like when people are willing to share data, compare results, and learn from one another.

With 424 samples submitted, dozens of fungal species represented, increasingly sophisticated chemical analysis, and entrepreneurs pushing the boundaries of extraction and formulation, the 2026 competition demonstrated that psychedelic innovation is no longer confined to the familiar world of magic mushroom cultivation.

The next chapter will likely be shaped by better analytical tools, more transparent products, and a growing recognition that understanding these organisms requires looking well beyond a single potency number.

For more information, Tryptomics' publicly accessible competition results and analytical data can be found at tryptomics.com/leaderboard.

Topic: Mycopreneur Incubator
Time: Nov 5, 2026 03:00 PM U.S. EST / 12 PM PST

Join Zoom Meeting
https://us06web.zoom.us/j/87575277676?pwd=w5k1GGlfZ22I3SOtolZbZokYnxpUi8.1

Join and take notes
https://us06web.zoom.us/j/87575277676?pwd=w5k1GGlfZ22I3SOtolZbZokYnxpUi8.1&mynotes=on